"Humanized mice" refer to mouse models that carry functional human genes, cells, tissues, or organs/immune systems and can be used for biomedical research and the development of clinical treatment strategies. One notable category within this field is the creation of mice with humanized immune systems, often referred to as humanized immune system mice. These models are developed by transplanting human hematopoietic stem cells, immune cells, or tissues into immunodeficient mice, resulting in a unique mouse model with human immune functionality.
Humanized immune system mice are classified into three distinct categories based on the methodology employed for immune system reconstruction:
Prominent examples of humanized immune system mouse models include humanized PBMC (huPBMC) mice and humanized HSC (huHSC) mice. Cyagen’s NKG immunodeficient mice offer versatility, accommodating transplantation with either PBMCs or HSCs to construct highly effective human immune system mouse models.
This innovative approach facilitates a more accurate simulation of the human immune response, providing exceptional models for preclinical research across various areas, including tumor immunology, autoimmune diseases, and specific infectious diseases.
| Mouse Name | Project Time | Immune Reconstitution Status | Research Applications | Order |
|---|---|---|---|---|
| huPBMC-NKG | Achieving a humanization ratio of over 40% within 3 weeks. | Predominantly T cells, accounting for over 90%. | Tumor immunology research; anti-GvHD drug research; infectious disease research; gene therapy; drug target research without cross-reactivity; immunogenicity assays. | Inquire Now |
| huHSC-NKG | Reaching a humanization ratio of over 50% within 8 weeks. | Reconstruction of various immune cells. | Tumor research; immunology research; autoimmune disease research; drug metabolism and toxicity research. | Inquire Now |
| huHSC-NKG-hIL15 | Rapid reconstruction achieved in the 3rd week post-transplantation; | Reconstruction of various immune cells, especially effective reconstruction of human-derived NK cells; | Studies on NK cell development mechanisms, development of NK cell-related tumor immunotherapy, studies on antibody-dependent NK cell-mediated cytotoxicity (ADCC); research on human immune and hematopoietic systems. | Inquire Now |
| huHSC-NKG-ProF | The humanization ratio reaches 40-60% in 8 weeks | Reconstitution of lymphoid T, B, and NK cells, as well as myeloid dendritic cells (DC), monocytes, macrophages, and granulocytes | Tumor Immunology Research; Autoimmune Disease Research; Drug Metabolism and Toxicity Research | Inquire Now |
| huHSC-NKG-ProM | The humanization ratio reaches 40-60% in 8 weeks | Reconstituted lymphoid T and B cells, as well as myeloid monocytes | Tumor Immunology Research; Autoimmune Disease Research; Drug Metabolism and Toxicity Research | Inquire Now |
| huHSC-NKG-ProN | The humanization ratio reaches 40-60% in 8 weeks | Reconstituted lymphoid T, B, and NK cells | Tumor Immunology Research; Drug Metabolism and Toxicity Research | Inquire Now |